Westlake Chemical Partners LP (WLKP) Stock Analysis and Metrics

Westlake Chemical Partners

NYSE: WLKP

$22.14 ▲ +0.13 (+0.59%)

At close: Jul 24, 2026 · 3:51 PM UTC

Financial Ratios

Market Cap775.06 Mn

P/E2.29

P/S0.63

Div. Yield0.04

Total Debt (Qtr)377.06 Mn

Revenue Growth (1y) (Qtr)28.64

Add ratio to table…

About

Westlake Chemical Partners LP is a Delaware limited partnership formed in March 2014 to operate acquire and develop ethylene production facilities and related assets through its interest in OpCo. The partnership holds a limited partnership interest in OpCo and owns the general partner interest giving it control over all of OpCo's assets and operations. OpCo's asset base consists of three ethylene production facilities located in Louisiana and Kentucky and a 200 mile ethylene pipeline that runs from Texas to Texas. These facilities convert ethane into ethylene which is used as a feedstock for polyethylene and polyvinyl chloride production.

The partnership generates revenue primarily from the sale of ethylene to Westlake under a long term cost plus agreement that provides a fixed margin per pound. Under this agreement Westlake commits to purchase approximately 95% of OpCo's planned ethylene production each year. Any ethylene not taken by Westlake and the co products of ethylene production, including propylene, crude butadiene, pyrolysis gasoline and hydrogen, are sold to third party customers on either a spot or contract basis. The partnership also earns revenue from the sale of these co products which are marketed to chemical manufacturers and other industrial users. Revenue is recognized when title transfers and the associated costs are covered by the cost plus mechanism or market prices for third party sales.

The company operates through a single reportable segment that encompasses all of its ownership interests in OpCo and related operations. This segment is not divided by geography or product line but is treated as one unit for reporting purposes.

• Single Reportable Segment: This segment encompasses the ownership of a 22.8% limited partnership interest in OpCo and the general partner interest that provides control over OpCo's assets. The segment generates revenue from ethylene sales to Westlake under a long term cost plus agreement and from the sale of co products such as propylene, crude butadiene, pyrolysis gasoline and hydrogen to third party customers.

Ethylene is the world's most widely used petrochemical by volume and serves as a fundamental building block for plastics such as polyethylene and polyvinyl chloride. Westlake Chemical Partners LP holds a strategic position because its parent company Westlake consumes the majority of the ethylene produced by OpCo through downstream polyethylene and polyvinyl chloride plants. This relationship reduces exposure to merchant market volatility for approximately 95% of output while the remaining five percent and any excess volumes compete with regional producers. Key competitors in the merchant ethylene market include LyondellBasell Industries NV, Shell Chemical Company, BASF Corporation and Motiva Enterprises LLC. The partnership’s competitive advantages stem from its long term contracts, cost plus pricing structure and control of the general partner interest which allows it to influence operational decisions and cash distribution.

The partnership’s primary customer is Westlake which purchases approximately 95% of the ethylene produced under the long term agreement. Westlake uses this ethylene mainly as feedstock for its polyethylene and polyvinyl chloride manufacturing facilities located in Louisiana Texas and other sites. The remaining ethylene and co products such as propylene crude butadiene pyrolysis gasoline and hydrogen are sold to a diverse group of third party industrial customers including chemical manufacturers refiners and other downstream users. While specific third party names are not disclosed the customer base spans multiple sectors that rely on these intermediates for their own production processes. Revenue from third party sales is subject to market prices and is influenced by regional supply and demand dynamics.

Investment Thesis

▲ Bull case

Westlake Chemical Partners LP’s core strength lies in its highly predictable and stable cash flow model, which is underappreciated by the market amid broader commodity sector volatility. The fixed-margin ethylene sales agreement with Westlake Corporation guarantees a $0.10 per pound margin on 95% of production, insulating the partnership from feedstock and ethylene price swings that plague pure-play chemical producers. This structural advantage was evident in Q1 2026, where despite only modest production volumes following the prior year’s Petro 1 turnaround, the partnership still delivered $14.2 million in net income and $17.9 million in MLP distributable cash flow—representing a 280% year-over-year increase. The market is overlooking how this base level of cash flow generation provides a powerful floor, especially as the partnership approaches a full year of normalized operations post-turnaround. With no planned turnarounds in 2026, utilization rates are expected to steadily climb toward historical averages, directly translating into higher absolute dollar contributions to distributable cash flow without any increase in operational risk. This creates a compounding effect where each incremental percentage point of utilization improvement flows almost directly to the bottom line due to the fixed-cost nature of the business. Furthermore, the partnership’s balance sheet remains exceptionally conservative, with a consolidated leverage ratio of approximately 1.0x and $81 million in combined cash and investments under its management agreement with Westlake Corporation. This liquidity buffer, combined with minimal near-term capital requirements, positions Westlake Chemical Partners LP to not only sustain its 47-quarter streak of distributions but also to consider modest growth initiatives—such as negotiating a higher fixed margin in its ethylene supply agreement or pursuing bolt-on acquisitions—without jeopardizing its distribution coverage. The market’s focus on near-term commodity price noise is missing the long-term value of this toll-like structure, which delivers bond-like income with equity-like upside potential as utilization normalizes.
The geopolitical disruption stemming from the conflict in the Middle East and the closure of the Strait of Hormuz is creating a durable tailwind for Westlake Chemical Partners LP that extends beyond a temporary pricing bump. Management noted in the Q1 2026 call that global chemical customers are increasingly sourcing material from North America due to supply chain insecurity, a trend that is supporting sustained demand and pricing strength for domestically produced ethylene. While only 5% of output is sold to third parties at market-linked prices, the partnership demonstrated its ability to capitalize on this environment by deliberately increasing third-party sales volumes in March 2026 when ethylene prices spiked—a tactical move that improved margins without disrupting its core contracted business. This flexibility to pivot toward higher-margin spot opportunities when market conditions allow represents an underrecognized source of optionality. The market is treating this as a transient benefit tied to the current conflict, but the underlying shift toward regionalization of chemical supply chains—driven by concerns over maritime chokepoints and geopolitical risk—is likely to persist even if tensions ease. As a result, Westlake Chemical Partners LP could see structurally higher baseline pricing for its third-party sales over the medium term, especially if North American ethylene continues to trade at a premium to imported volumes due to logistics advantages and supply certainty. This dynamic enhances the partnership’s ability to generate incremental cash flow beyond its fixed-margin base, with the potential to steadily improve distribution coverage ratios over time. More importantly, this environment strengthens the partnership’s negotiating position with Westlake Corporation when revisiting the ethylene sales agreement, as the demonstrated ability to capture value in dislocated markets underscores the strategic importance of its Gulf Coast assets.
Westlake Chemical Partners LP is quietly building toward a future where ownership growth and operational enhancements could meaningfully accelerate distribution growth, yet these levers are not being priced into current expectations. The partnership has explicitly outlined four growth avenues: increasing its ownership stake in OpCo, acquiring complementary income streams, pursuing organic expansions (such as adding ethylene capacity at existing facilities), and renegotiating a higher fixed margin in its ethylene supply agreement. While none of these were highlighted as imminent catalysts in the Q1 2026 call, the absence of planned turnarounds in 2026 creates a unique window to evaluate capital allocation toward such initiatives. For instance, expanding capacity at the Lake Charles or Calvert City facilities—both of which have available infrastructure and access to feedstock—could be pursued with relatively low execution risk given the partnership’s deep operational expertise and existing off-take agreements. Even a modest 10% increase in ethylene output, sold under the current $0.10 per pound fixed margin, would generate approximately $2.0 million in additional annual gross profit before operating costs, directly boosting distributable cash flow. More significantly, any increase in ownership interest in OpCo would allow the partnership to capture a larger share of the subsidiary’s robust cash flows, which in Q1 2026 alone generated over $81 million in net income attributable to noncontrolling interest. The market is currently valuing Westlake Chemical Partners LP almost exclusively on its existing cash flow stream, failing to assign value to these embedded growth options. This is particularly noteworthy given the partnership’s strong sponsorship by Westlake Corporation, which provides both financial backing and strategic alignment—making accretive acquisitions or joint ventures more feasible than for standalone MLPs. As utilization continues to normalize and cash flow stability reinforces investor confidence, the partnership may begin to incrementally deploy capital toward these higher-return initiatives, creating a stealthy compounding effect that could significantly outpace current distribution growth expectations.

Westlake Chemical Partners LP’s core strength lies in its highly predictable and stable cash flow model, which is underappreciated by the market amid broader commodity sector volatility. The fixed-margin ethylene sales agreement with Westlake Corporation guarantees a $0.10 per pound margin on 95% of production, insulating the partnership from feedstock and ethylene price swings that plague pure-play chemical producers. This structural advantage was evident in Q1 2026, where despite only modest production volumes following the prior year’s Petro 1 turnaround, the partnership still delivered $14.2 million in net income and $17.9 million in MLP distributable cash flow—representing a 280% year-over-year increase. The market is overlooking how this base level of cash flow generation provides a powerful floor, especially as the partnership approaches a full year of normalized operations post-turnaround. With no planned turnarounds in 2026, utilization rates are expected to steadily climb toward historical averages, directly translating into higher absolute dollar contributions to distributable cash flow without any increase in operational risk. This creates a compounding effect where each incremental percentage point of utilization improvement flows almost directly to the bottom line due to the fixed-cost nature of the business. Furthermore, the partnership’s balance sheet remains exceptionally conservative, with a consolidated leverage ratio of approximately 1.0x and $81 million in combined cash and investments under its management agreement with Westlake Corporation. This liquidity buffer, combined with minimal near-term capital requirements, positions Westlake Chemical Partners LP to not only sustain its 47-quarter streak of distributions but also to consider modest growth initiatives—such as negotiating a higher fixed margin in its ethylene supply agreement or pursuing bolt-on acquisitions—without jeopardizing its distribution coverage. The market’s focus on near-term commodity price noise is missing the long-term value of this toll-like structure, which delivers bond-like income with equity-like upside potential as utilization normalizes.
The geopolitical disruption stemming from the conflict in the Middle East and the closure of the Strait of Hormuz is creating a durable tailwind for Westlake Chemical Partners LP that extends beyond a temporary pricing bump. Management noted in the Q1 2026 call that global chemical customers are increasingly sourcing material from North America due to supply chain insecurity, a trend that is supporting sustained demand and pricing strength for domestically produced ethylene. While only 5% of output is sold to third parties at market-linked prices, the partnership demonstrated its ability to capitalize on this environment by deliberately increasing third-party sales volumes in March 2026 when ethylene prices spiked—a tactical move that improved margins without disrupting its core contracted business. This flexibility to pivot toward higher-margin spot opportunities when market conditions allow represents an underrecognized source of optionality. The market is treating this as a transient benefit tied to the current conflict, but the underlying shift toward regionalization of chemical supply chains—driven by concerns over maritime chokepoints and geopolitical risk—is likely to persist even if tensions ease. As a result, Westlake Chemical Partners LP could see structurally higher baseline pricing for its third-party sales over the medium term, especially if North American ethylene continues to trade at a premium to imported volumes due to logistics advantages and supply certainty. This dynamic enhances the partnership’s ability to generate incremental cash flow beyond its fixed-margin base, with the potential to steadily improve distribution coverage ratios over time. More importantly, this environment strengthens the partnership’s negotiating position with Westlake Corporation when revisiting the ethylene sales agreement, as the demonstrated ability to capture value in dislocated markets underscores the strategic importance of its Gulf Coast assets.
Westlake Chemical Partners LP is quietly building toward a future where ownership growth and operational enhancements could meaningfully accelerate distribution growth, yet these levers are not being priced into current expectations. The partnership has explicitly outlined four growth avenues: increasing its ownership stake in OpCo, acquiring complementary income streams, pursuing organic expansions (such as adding ethylene capacity at existing facilities), and renegotiating a higher fixed margin in its ethylene supply agreement. While none of these were highlighted as imminent catalysts in the Q1 2026 call, the absence of planned turnarounds in 2026 creates a unique window to evaluate capital allocation toward such initiatives. For instance, expanding capacity at the Lake Charles or Calvert City facilities—both of which have available infrastructure and access to feedstock—could be pursued with relatively low execution risk given the partnership’s deep operational expertise and existing off-take agreements. Even a modest 10% increase in ethylene output, sold under the current $0.10 per pound fixed margin, would generate approximately $2.0 million in additional annual gross profit before operating costs, directly boosting distributable cash flow. More significantly, any increase in ownership interest in OpCo would allow the partnership to capture a larger share of the subsidiary’s robust cash flows, which in Q1 2026 alone generated over $81 million in net income attributable to noncontrolling interest. The market is currently valuing Westlake Chemical Partners LP almost exclusively on its existing cash flow stream, failing to assign value to these embedded growth options. This is particularly noteworthy given the partnership’s strong sponsorship by Westlake Corporation, which provides both financial backing and strategic alignment—making accretive acquisitions or joint ventures more feasible than for standalone MLPs. As utilization continues to normalize and cash flow stability reinforces investor confidence, the partnership may begin to incrementally deploy capital toward these higher-return initiatives, creating a stealthy compounding effect that could significantly outpace current distribution growth expectations.

▼ Bear case

Westlake Chemical Partners LP’s distributable cash flow remains dangerously close to distribution levels, leaving minimal margin for error and exposing unitholders to the risk of future cuts if operational or market headwinds emerge. Despite the partnership’s emphasis on its 47-quarter distribution streak, the Q1 2026 results reveal a fragile foundation: MLP distributable cash flow was $17.9 million, while distributions declared totaled $16.6 million, resulting in a razor-thin coverage ratio of just 1.08x for the quarter. This coverage has only recently climbed above 1.0x after being as low as 0.82x at the end of 2025, and the partnership’s own guidance indicates that this improvement is largely attributable to the lapping of the negative impact from the Petro 1 turnaround in 2025—not to structural strength. With no turnarounds planned in 2026, the comparison will flip, meaning future quarters will face tougher year-over-year comparisons as the benefit of reduced maintenance capital expenditures and higher post-turnaround utilization fades. The partnership’s trailing twelve-month coverage ratio improved to 1.00x in Q1 2026 from 0.82x in Q4 2025, but this still leaves virtually no buffer against even minor disruptions. A single unplanned outage, a modest decline in third-party margins, or a temporary increase in maintenance spending could quickly push coverage below 1.0x, jeopardizing the distribution. The market may be placing too much faith in the partnership’s historical stability, but the current cash flow dynamics show that Westlake Chemical Partners LP is operating with a minimalist buffer—one that could be eroded not by catastrophe, but by the simple reversion to mean utilization and spending patterns as the turnover benefits fully normalize.
The partnership’s heavy reliance on Westlake Corporation creates significant counterparty and structural risks that are not being adequately scrutinized by investors. While the fixed-margin ethylene sales agreement provides stability, it also binds Westlake Chemical Partners LP’s fortunes entirely to the decisions and financial health of its parent company. The agreement grants Westlake Corporation control over 95% of output at a fixed $0.10 per pound margin, meaning the partnership has no ability to benefit from strong ethylene markets beyond its small third-party sales slice. More critically, Westlake Corporation retains the right to modify or not renew the agreement, and there is no guarantee that the current margin will be sustained in future negotiations—especially if Westlake seeks to pull more value upstream as integrated refining and chemical margins face pressure. The partnership’s growth outlook is explicitly tied to negotiating a higher fixed margin, yet this is entirely dependent on Westlake’s willingness to concede, which may diminish if the parent company prioritizes its own profitability. Furthermore, the potential for increased ownership in OpCo—cited as a growth lever—would require Westlake Corporation to sell down its stake, which it may be unwilling to do if it views OpCo as a strategic asset. This creates a fundamental misalignment: investors in Westlake Chemical Partners LP are betting on continued parental support, but there is no contractual guarantee that Westlake Corporation will act in the partnership’s best interest over the long term. The market is treating the relationship as symbiotic and durable, but in reality, the partnership is a subordinate entity with limited agency, making it vulnerable to shifts in parent company strategy that could leave it with unattractive contract terms or stalled growth prospects.
The partnership’s exposure to regional demand shifts and global trade flows introduces volatility that contradicts its narrative of pure stability, particularly as its third-party sales channel—though small—has become a key narrative driver for near-term optimism. Management highlighted that the Middle East conflict and closure of the Strait of Hormuz are driving increased demand for North American ethylene, enabling the partnership to capture incremental margin by selling more volumes to third parties at spot prices. However, this narrative is inherently transient and reversible: if global shipping lanes reopen, geopolitical tensions ease, or overseas producers ramp up capacity to regain market share, the premium for North American ethylene could rapidly dissipate. The partnership’s own comments acknowledged that the benefit was only clearly visible in March 2026 (one month of activity), and while they expect more impact in Q2, there is no indication this will become a permanent feature of the business model. Worse, the partnership’s increase in third-party sales volume came at the expense of year-over-year declines in third-party sales revenue—a contradiction that suggests they are selling more volume but at prices that, while higher than last year’s depressed levels, may still be below historical norms. This dynamic reveals that the partnership is not structurally benefiting from the conflict, but rather engaging in tactical volume shifting to catch up from a weak prior-year baseline. As the lapping effect of the 2025 turnaround fades, any perceived gain from third-party sales could vanish, leaving the partnership exposed to the same commodity cycles it claims to have insulated itself from. The market is rewarding a temporary tactical adjustment as if it were a structural improvement, failing to recognize that the core business remains tightly contracted and thus largely immune to—yet also unable to meaningfully capitalize on—favorable market conditions beyond its minimal discretionary volume.

Westlake Chemical Partners LP’s distributable cash flow remains dangerously close to distribution levels, leaving minimal margin for error and exposing unitholders to the risk of future cuts if operational or market headwinds emerge. Despite the partnership’s emphasis on its 47-quarter distribution streak, the Q1 2026 results reveal a fragile foundation: MLP distributable cash flow was $17.9 million, while distributions declared totaled $16.6 million, resulting in a razor-thin coverage ratio of just 1.08x for the quarter. This coverage has only recently climbed above 1.0x after being as low as 0.82x at the end of 2025, and the partnership’s own guidance indicates that this improvement is largely attributable to the lapping of the negative impact from the Petro 1 turnaround in 2025—not to structural strength. With no turnarounds planned in 2026, the comparison will flip, meaning future quarters will face tougher year-over-year comparisons as the benefit of reduced maintenance capital expenditures and higher post-turnaround utilization fades. The partnership’s trailing twelve-month coverage ratio improved to 1.00x in Q1 2026 from 0.82x in Q4 2025, but this still leaves virtually no buffer against even minor disruptions. A single unplanned outage, a modest decline in third-party margins, or a temporary increase in maintenance spending could quickly push coverage below 1.0x, jeopardizing the distribution. The market may be placing too much faith in the partnership’s historical stability, but the current cash flow dynamics show that Westlake Chemical Partners LP is operating with a minimalist buffer—one that could be eroded not by catastrophe, but by the simple reversion to mean utilization and spending patterns as the turnover benefits fully normalize.
The partnership’s heavy reliance on Westlake Corporation creates significant counterparty and structural risks that are not being adequately scrutinized by investors. While the fixed-margin ethylene sales agreement provides stability, it also binds Westlake Chemical Partners LP’s fortunes entirely to the decisions and financial health of its parent company. The agreement grants Westlake Corporation control over 95% of output at a fixed $0.10 per pound margin, meaning the partnership has no ability to benefit from strong ethylene markets beyond its small third-party sales slice. More critically, Westlake Corporation retains the right to modify or not renew the agreement, and there is no guarantee that the current margin will be sustained in future negotiations—especially if Westlake seeks to pull more value upstream as integrated refining and chemical margins face pressure. The partnership’s growth outlook is explicitly tied to negotiating a higher fixed margin, yet this is entirely dependent on Westlake’s willingness to concede, which may diminish if the parent company prioritizes its own profitability. Furthermore, the potential for increased ownership in OpCo—cited as a growth lever—would require Westlake Corporation to sell down its stake, which it may be unwilling to do if it views OpCo as a strategic asset. This creates a fundamental misalignment: investors in Westlake Chemical Partners LP are betting on continued parental support, but there is no contractual guarantee that Westlake Corporation will act in the partnership’s best interest over the long term. The market is treating the relationship as symbiotic and durable, but in reality, the partnership is a subordinate entity with limited agency, making it vulnerable to shifts in parent company strategy that could leave it with unattractive contract terms or stalled growth prospects.
The partnership’s exposure to regional demand shifts and global trade flows introduces volatility that contradicts its narrative of pure stability, particularly as its third-party sales channel—though small—has become a key narrative driver for near-term optimism. Management highlighted that the Middle East conflict and closure of the Strait of Hormuz are driving increased demand for North American ethylene, enabling the partnership to capture incremental margin by selling more volumes to third parties at spot prices. However, this narrative is inherently transient and reversible: if global shipping lanes reopen, geopolitical tensions ease, or overseas producers ramp up capacity to regain market share, the premium for North American ethylene could rapidly dissipate. The partnership’s own comments acknowledged that the benefit was only clearly visible in March 2026 (one month of activity), and while they expect more impact in Q2, there is no indication this will become a permanent feature of the business model. Worse, the partnership’s increase in third-party sales volume came at the expense of year-over-year declines in third-party sales revenue—a contradiction that suggests they are selling more volume but at prices that, while higher than last year’s depressed levels, may still be below historical norms. This dynamic reveals that the partnership is not structurally benefiting from the conflict, but rather engaging in tactical volume shifting to catch up from a weak prior-year baseline. As the lapping effect of the 2025 turnaround fades, any perceived gain from third-party sales could vanish, leaving the partnership exposed to the same commodity cycles it claims to have insulated itself from. The market is rewarding a temporary tactical adjustment as if it were a structural improvement, failing to recognize that the core business remains tightly contracted and thus largely immune to—yet also unable to meaningfully capitalize on—favorable market conditions beyond its minimal discretionary volume.

Peer Comparison

Companies in the Chemicals

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	CE	Celanese Corp	5.19 Bn	-305.45	0.55	12.55 Bn
2	MEOH	Methanex Corp	4.49 Bn	-83.59	1.22	2.71 Bn
3	OLN	OLIN Corp	2.69 Bn	-14.55	0.40	3.00 Bn
4	BAK	Braskem Sa	1.98 Bn	-8.33	0.15	9.61 Bn
5	REX	REX AMERICAN RESOURCES Corp	1.49 Bn	17.71	2.29	-
6	GPRE	Green Plains Inc.	1.18 Bn	90.00	0.61	0.46 Bn
7	TROX	Tronox Holdings plc	1.02 Bn	-2.18	0.35	3.16 Bn
8	LXU	Lsb Industries, Inc.	0.88 Bn	18.77	1.37	0.45 Bn

Research Tools

Developers

About

Investment Thesis

Related and Nonrelated Parties Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Related and Nonrelated Parties Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password